Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001487548 | SCV001692038 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2023-10-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002432367 | SCV002741073 | uncertain significance | Cardiovascular phenotype | 2021-08-26 | criteria provided, single submitter | clinical testing | The p.A833T variant (also known as c.2497G>A), located in coding exon 21 of the JAG1 gene, results from a G to A substitution at nucleotide position 2497. The alanine at codon 833 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002495730 | SCV002808341 | likely benign | Alagille syndrome due to a JAG1 point mutation; Tetralogy of Fallot; Deafness, congenital heart defects, and posterior embryotoxon; Charcot-Marie-Tooth disease, axonal, Type 2HH | 2022-05-20 | criteria provided, single submitter | clinical testing |